Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

214 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

2706 (92%)

2930

Discontinuation Reports

To be discontinued:

2 (1%)

Discontinued:

298 (99%)

Reversed:

0 (0%)

300

363 (11%)

99 (46%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2020-09-24 2020-11-12 125007
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2020-11-27 2020-12-17 129050
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2022-12-01 2023-06-09 176818
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-19 2023-06-27 195515
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2023-06-20 2023-06-27 195844
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2021-07-22 2021-09-02 142908
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2020-06-04 2020-07-09 116684
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2020-06-04 2020-08-21 116690
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Resolved 2024-10-11 2024-11-08 240040
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Resolved 2024-10-11 2024-11-01 240043
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-11-28 2025-04-10 244078
TEVA-TOLTERODINE LA 4MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-12-13 2025-03-20 245615
TEVA-TOLTERODINE LA 2MG CAPSULE (EXTENDED RELEASE) Actual shortage 2024-12-19 2025-05-08 246118
TEVA-TOPILENE 0.05% OINTMENT Actual shortage 2024-10-11 2025-05-08 240072
TEVA-TOPILENE 0.05% LOTION Resolved 2024-12-13 2025-02-06 245595
TEVA-TOPILENE 0.05% CREAM Actual shortage 2025-04-24 2025-05-02 255681
TEVA-TOPILENE 0.05% CREAM Resolved 2020-06-25 2020-09-25 118942
TEVA-TOPILENE 0.05% OINTMENT Resolved 2020-06-25 2020-10-01 118948
TEVA-TOPILENE 0.05% CREAM Resolved 2024-02-08 2024-07-18 218949
TEVA-TOPILENE 0.05% CREAM Resolved 2024-02-29 2024-07-18 220989
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
CLOXACILLIN SODIUM FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14018
CLOXACILLIN SODIUM FOR INJECTION 2G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14021
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
EPIRUBICIN FOR INJECTION 2MG SOLUTION Discontinued 2020-10-22 2020-10-24 126906
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Discontinued 2017-06-27 2017-06-27 14024
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106176
EPTIFIBATIDE INJECTION 2MG SOLUTION Discontinued 2017-06-27 2017-06-27 14027
FLUDARABINE PHOSPHATE FOR INJECTION 25MG SOLUTION Discontinued 2025-10-22 2025-10-22 257579
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
GEMCITABINE FOR INJECTION 1G POWDER FOR SOLUTION Discontinued 2017-06-27 2017-06-27 14033
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
HYDROCORTISONE SODIUM SUCCINATE INJECTION Discontinued 2019-04-11 2019-04-11 81347
LEUCOVORIN CALCIUM INJECTION 10MG SOLUTION Discontinued 2017-06-27 2017-06-27 14036
LINEZOLID INJECTION Discontinued 2020-02-13 2020-02-13 106173